Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma

DP Bender, JI Sorosky, RE Buller, AK Sood - American journal of obstetrics …, 2003 - Elsevier
Objective: The purpose of this study was to determine the prognostic significance of a
pretreatment serum CA 125 value in patients who were diagnosed with adenocarcinoma of …

[HTML][HTML] Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers

I Sidorkiewicz, M Zbucka-Krętowska, K Zaręba… - BMC cancer, 2019 - Springer
Background The search of useful serum biomarkers for the early detection of cervical
cancers has been of a high priority. The activation of Macrophage-Colony Stimulating Factor …

Prospective Evaluation of Squamous Cell Carcinomaand Carcinoembryonic Antigen as Prognostic Factors in Patients with Cervical Cancer

R Molina, X Filella, JA Lejarcegui, J Pahisa, A Torné… - Tumor biology, 2003 - karger.com
Carcinoembryonic antigen (CEA) and squamous cell carcinoma (SCC) serum levels were
prospectively determined in 159 untreated patients diagnosed with carcinoma of the uterine …

Increased carcinoembryonic antigen expression in cervical intraepithelial neoplasia grade 3 and in cervical squamous cell carcinoma

A Tendler, HL Kaufman, AS Kadish - Human pathology, 2000 - Elsevier
Carcinoembryonic antigen (CEA) is a highly glycosylated cell surface protein that is
overexpressed in a variety of human tumors and has been used as a tumor marker for …

Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study

R Czerninski, JR Basile, T Kartin‐Gabay, A Laviv… - Oral …, 2014 - Wiley Online Library
Objective To evaluate serum levels of interleukin (IL)‐1, IL‐6, IL‐8, IL‐10, soluble IL‐2
receptor (sIL‐2R), squamous cell carcinoma antigen (SCCA), tissue polypeptide–specific …

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix

T Kaku, K Sonoda, T Kamura, T Hirakawa, K Sakai… - Clinical cancer …, 1999 - AACR
We previously established (K. Sonoda et al., Int. J. Oncol., 6: 1099–1104, 1995) a novel
monoclonal antibody, 22-1-1, generated from adenocarcinoma of the uterine cervix, and 22 …

Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix

SN Bae, SE Namkoong, JK Jung, CJ Kim, JS Park… - Gynecologic …, 1997 - Elsevier
Sixty-seven patients with squamous cell carcinoma of the uterine cervix (FIGO Stages IB2,
IIA, and IIB) were reviewed to evaluate the pretreatment level of squamous cell carcinoma …

Multiple tumour marker assays in advanced cervical cancer: relationship to chemotherapy response and clinical outcome

G Scambia, PB Panici, E Foti, G Ferrandina… - European Journal of …, 1996 - Elsevier
Serum levels of squamous cell carcinoma antigen (SCC), CA 125 and CA 15.3 were
measured in 102 patients with locally advanced cervical cancer undergoing neoadjuvant …

Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma

T Tabata, N Takeshima, N Tanaka, Y Hirai, K Hasumi - Tumor biology, 2000 - karger.com
Objective: The clinical value of tumor markers for early detection of recurrence was
investigated in 32 patients with cervical adenocarcinoma or adenosquamous carcinoma …

Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix

YT Kim, BS Yoon, JW Kim, SH Kim, JY Kwon… - International Journal of …, 2005 - Elsevier
Objectives: To investigate whether pretreatment levels of serum squamous cell carcinoma
antigen (SCCA) and urine polyamines can predict lymph node metastases in patients with …